The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters
用户wEPMgFb_HJo8
1天前
39
10
已关闭
DOI:
文献链接:
其他信息:
N Higashi, Y Niimi, M Aoki, K Fujimoto, K Suzuki…
Arerugi …, 2003
europepmc.org
The Th2 cytokine inhibitor, suplatast tosilate (300 mg/day) was administered to 45 cases of patients with atopic dermatitis for 8 weeks. The clinical scores, peripheral blood eosinophil counts, serum LDH levels, total IgE levels, serum eosinophil cationic protein (ECP) levels, and serum IL-5 levels before and after the treatment were observed and comparatively evaluated. The results of this study were summarized as follows. 1) Temporary improvements were found in the severity score, itching score, and sleeplessness score. All …
